S Korea's Peak Bio to go public on Nasdaq via SPAC deal

S Korea's Peak Bio to go public on Nasdaq via SPAC deal

Photo by RephiLe on Unsplash

03 May, 2022

biopharmaceutical inflammatory diseases NASDAQ Oncology Peak Bio SPAC

Printed by Unregistered user on Fri, 25 Jul 2025 23:47:53 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese EV company CH-AUTO to go public via $1.7 billion SPAC deal

Will downbeat market sentiment affect SPAC prospects in Singapore, HK?

Read more from Greater China

Chinese e-commerce giants defend ‘instant retail’ strategy despite state pressure

Hong Kong-based crypto platform OSL Group raises $300m equity funding